CH695983A5 - Tetraiodthyropropionsäure oder Tetraiodthyroessigsäure zur Herstellung eines dermatologischen Präparates. - Google Patents
Tetraiodthyropropionsäure oder Tetraiodthyroessigsäure zur Herstellung eines dermatologischen Präparates. Download PDFInfo
- Publication number
- CH695983A5 CH695983A5 CH01666/02A CH16662002A CH695983A5 CH 695983 A5 CH695983 A5 CH 695983A5 CH 01666/02 A CH01666/02 A CH 01666/02A CH 16662002 A CH16662002 A CH 16662002A CH 695983 A5 CH695983 A5 CH 695983A5
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- plaque
- thyroid hormone
- ointment
- plaques
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20000818A FI107018B (fi) | 2000-04-06 | 2000-04-06 | Dermatologinen käyttö ja valmiste |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH695983A5 true CH695983A5 (de) | 2006-11-15 |
Family
ID=8558139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH01666/02A CH695983A5 (de) | 2000-04-06 | 2001-02-05 | Tetraiodthyropropionsäure oder Tetraiodthyroessigsäure zur Herstellung eines dermatologischen Präparates. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20030144359A1 (OSRAM) |
| EP (1) | EP1274416A1 (OSRAM) |
| JP (1) | JP2003530349A (OSRAM) |
| AU (1) | AU2001235506A1 (OSRAM) |
| CA (1) | CA2405425A1 (OSRAM) |
| CH (1) | CH695983A5 (OSRAM) |
| DE (1) | DE10196025T1 (OSRAM) |
| DK (1) | DK200201483A (OSRAM) |
| ES (1) | ES2193003B1 (OSRAM) |
| FI (1) | FI107018B (OSRAM) |
| GB (1) | GB2377380B (OSRAM) |
| NO (1) | NO20024810L (OSRAM) |
| SE (1) | SE0202886L (OSRAM) |
| WO (1) | WO2001076589A1 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11508241A (ja) * | 1995-06-07 | 1999-07-21 | カロ バイオ エービー | 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用 |
| US8668926B1 (en) | 2003-09-15 | 2014-03-11 | Shaker A. Mousa | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| US9198887B2 (en) | 2003-09-15 | 2015-12-01 | Nanopharmaceuticals Llc | Thyroid hormone analogs and methods of use |
| JP2007505837A (ja) * | 2003-09-15 | 2007-03-15 | オードウェイ リサーチ インスティテュート | 甲状腺ホルモンアナログおよび新脈管形成における使用の方法 |
| US9498536B2 (en) | 2005-09-15 | 2016-11-22 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders |
| US10130686B2 (en) | 2005-09-15 | 2018-11-20 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders |
| US9220788B2 (en) | 2009-06-17 | 2015-12-29 | Nanopharmaceuticals Llc | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| WO2007035612A2 (en) | 2005-09-16 | 2007-03-29 | Ordway Research Institute, Inc. | Polyphenol conjugates as rgd-binding compounds and methods of use |
| JP2010513526A (ja) | 2006-12-22 | 2010-04-30 | シーエルエフ メディカル テクノロジー アクセラレーション プログラム インコーポレイテッド | 甲状腺ホルモン類縁体、拮抗剤および製剤のためのナノ粒子及び重合体製剤ならびにその使用 |
| WO2010075332A1 (en) * | 2008-12-23 | 2010-07-01 | Charitable Leadership Foundation | Small molecule ligands of the integrin rgd recognition site and methods of use |
| US9180107B2 (en) | 2009-03-31 | 2015-11-10 | Nanopharmaceuticals Llc | Combination treatment of cancer with cetuximab and tetrac |
| US8802240B2 (en) | 2011-01-06 | 2014-08-12 | Nanopharmaceuticals Llc | Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| US10201616B2 (en) | 2016-06-07 | 2019-02-12 | Nanopharmaceuticals, Llc | Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists |
| US11351137B2 (en) | 2018-04-11 | 2022-06-07 | Nanopharmaceuticals Llc | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US10328043B1 (en) | 2018-04-11 | 2019-06-25 | Nanopharmaceuticals, Llc. | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US10961204B1 (en) | 2020-04-29 | 2021-03-30 | Nanopharmaceuticals Llc | Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors |
| US11723888B2 (en) | 2021-12-09 | 2023-08-15 | Nanopharmaceuticals Llc | Polymer conjugated thyrointegrin antagonists |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB859546A (en) * | 1956-05-29 | 1961-01-25 | Arthur Alfred Hellbaum | Composition for treatment of the skin |
| US3198702A (en) * | 1960-03-17 | 1965-08-03 | Arthur A Hellbaum | Method for treating skin burns |
| CA2184002A1 (en) * | 1994-02-23 | 1995-08-31 | Jeffrey M. Blaney | Method and compositions for increasing the serum half-life of pharmacologically active agents |
| US6380255B1 (en) * | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| JPH11508241A (ja) * | 1995-06-07 | 1999-07-21 | カロ バイオ エービー | 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用 |
| HUT75956A (en) * | 1995-11-29 | 1997-05-28 | Cyclolab | Pharmaceutical composition containing thyroxine |
| US5951989A (en) * | 1997-04-07 | 1999-09-14 | Heymann; Warren R. | Method for the treatment of dry skin |
| GB9828442D0 (en) * | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| EP1173163B1 (en) * | 1999-04-26 | 2006-06-21 | Elliot Danforth, Jr. | Pharmaceutical compositions of tetrac and methods of use thereof |
| US6716877B2 (en) * | 2001-01-31 | 2004-04-06 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method to treat chronic heart failure and/or elevated cholesterol levels |
-
2000
- 2000-04-06 FI FI20000818A patent/FI107018B/fi active
-
2001
- 2001-02-05 DK DK200201483A patent/DK200201483A/da not_active Application Discontinuation
- 2001-02-05 CH CH01666/02A patent/CH695983A5/de not_active IP Right Cessation
- 2001-02-05 US US10/239,882 patent/US20030144359A1/en not_active Abandoned
- 2001-02-05 CA CA002405425A patent/CA2405425A1/en not_active Abandoned
- 2001-02-05 DE DE10196025T patent/DE10196025T1/de not_active Withdrawn
- 2001-02-05 GB GB0222880A patent/GB2377380B/en not_active Expired - Fee Related
- 2001-02-05 ES ES200250061A patent/ES2193003B1/es not_active Expired - Fee Related
- 2001-02-05 AU AU2001235506A patent/AU2001235506A1/en not_active Abandoned
- 2001-02-05 JP JP2001574107A patent/JP2003530349A/ja active Pending
- 2001-02-05 EP EP01907581A patent/EP1274416A1/en not_active Ceased
- 2001-02-05 WO PCT/FI2001/000100 patent/WO2001076589A1/en not_active Ceased
-
2002
- 2002-10-01 SE SE0202886A patent/SE0202886L/ not_active Application Discontinuation
- 2002-10-04 NO NO20024810A patent/NO20024810L/no not_active Application Discontinuation
-
2005
- 2005-08-08 US US11/198,133 patent/US20050272817A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SE0202886D0 (sv) | 2002-10-01 |
| US20050272817A1 (en) | 2005-12-08 |
| US20030144359A1 (en) | 2003-07-31 |
| DE10196025T1 (de) | 2003-03-13 |
| DK200201483A (da) | 2002-10-03 |
| AU2001235506A1 (en) | 2001-10-23 |
| GB0222880D0 (en) | 2002-11-13 |
| ES2193003A1 (es) | 2003-10-16 |
| NO20024810L (no) | 2002-12-06 |
| EP1274416A1 (en) | 2003-01-15 |
| GB2377380A (en) | 2003-01-15 |
| JP2003530349A (ja) | 2003-10-14 |
| FI20000818A0 (fi) | 2000-04-06 |
| FI107018B (fi) | 2001-05-31 |
| ES2193003B1 (es) | 2005-02-01 |
| GB2377380B (en) | 2004-07-14 |
| CA2405425A1 (en) | 2001-10-18 |
| WO2001076589A1 (en) | 2001-10-18 |
| NO20024810D0 (no) | 2002-10-04 |
| SE0202886L (sv) | 2002-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3880769T2 (de) | Topische Behandlung von Störungen kranker Haut. | |
| DE69730330T2 (de) | Verwendung von l-acetylcarnitin, l-isovalerylcarnitin oder l-propionyl-carnitin zur steigerung des igf-spiegels | |
| DE60000133T2 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
| DE69003015T4 (de) | Behandlung von Störungen in der Postmenopause. | |
| DE3005208A1 (de) | Verwendung von acylcarnitin in arzneimitteln zur behandlung von stoerungen im gehirn-metabolismus | |
| DE3621861A1 (de) | Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen | |
| WO1999049858A1 (de) | Verwendung von alkylhydrogenfumaraten zur behandlung von psoriasis, psoriatischer arthritis, neurodermitis und enteritis regionalis crohn | |
| DE3750934T2 (de) | Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten. | |
| DE4100975A1 (de) | Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualitaet und foerderung des haarwachstums | |
| DE3781182T2 (de) | Tamoxifen zur topischen verwendung. | |
| DE69934410T2 (de) | Behandlung von akne und lichtbedingter alterung durch kurzzeitbehandlung mit topischen retinoiden | |
| US20030144359A1 (en) | Dermatological use and a dermatological preparation | |
| DE68926115T2 (de) | Verfahren zur behandlung von akne | |
| DE69734838T2 (de) | Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten | |
| DE69804130T2 (de) | Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen | |
| CH654287A5 (de) | Verbindungen und kompositionen zur reduktion der sebumsekretion. | |
| DE69004532T2 (de) | Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen. | |
| EP0037488A2 (de) | Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen | |
| DE1804801C3 (de) | Mittel zur Aknebehandlung | |
| DE69228814T2 (de) | Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie | |
| DE69023939T2 (de) | Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten. | |
| DE2126533A1 (de) | Verfahren zur Herstellung pharma zeutischer Zubereitungen | |
| DE1667903C3 (de) | Verwendung von Cysteinderivaten zur Herstellung von per oral verabreichbaren Mitteln zur Bekämpfung der Seborrhoe | |
| DE4300969A1 (OSRAM) | ||
| DE2633891C2 (de) | Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-α-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUE | Assignment |
Owner name: PEKKA HEINO Free format text: IPSAT THERAPIES OY#SINIMAEENTIE 14B#02630 ESPOO (FI) -TRANSFER TO- PEKKA HEINO#LAHNARUOHONTIE 4 B 13#00200 HELSINKI (FI) |
|
| PL | Patent ceased |